Female Hormones Stimulate Body to Make Opioids, Easing Pain
What: UCSF researchers found female hormones trigger immune cells near the spinal cord to produce opioids, helping suppress pain before it reaches the brain.
Key Line: “’If that approach is successful, it could really change the lives of the nearly 20% of Americans who experience chronic pain that is not adequately treated,’ said study leader Allan Basbaum.”
Source: University of California – San Francisco
Mouse study reveals female hormones help trigger opioid production in spinal cord immune cells.
Carolina Public Press highlights potential solutions to the maternal care crisis in rural areas of North Carolina.
Studies reinforce that HRT timing may affect Alzheimer’s risk.
Study identifies fast, simple method for predicting life-threatening postpartum bleeding.
A prenatal test that detects fetal abnormalities has also been shown to identify cancer in pregnant women.
Treating male partners with antibiotics reduces BV recurrence.
CVS earns ‘menopause-friendly’ accreditation by Midovia after training clinicians and increasing internal education.
University of Calgary researchers found that female mice release leptin, a hormone associated with heightened pain sensitivity, which may explain why women experience more pain.
McKinsey examines how AI is poised to revolutionize the beauty industry, from marketing to product development.
A study of over 350,000 pregnancies found that 11% of women used cannabis before conception, and 6% used it during pregnancy, likely to manage nausea.
The U.S. Supreme Court appears inclined to allow Medicaid patients to continue receiving non-abortion care from Planned Parenthood.
World Economic Forum explores why improving diagnostics in women’s health is key.
Texas Democrats push for maternal mortality transparency and tracking.
FDA ends approval for compound versions of GLP-1 weight loss drugs.
Study finds no added benefit from multi-drug regimens for women with heart pain but no artery blockage.
The 19th highlights how removing “DEI” efforts puts research on women’s health at risk.
A New York Times analysis of an NBER study found that abortion bans led to higher birth rates, but not an overall increase in fertility.
Marty Makary faces controversies as the new FDA commissioner.
A systematic review found laser treatments improve menopause symptoms but do not enhance tissue quality.
A review on how abortion rates increased after Roe v. Wade was overturned.